4//SEC Filing
NeurogesX Inc 4
Accession 0001181431-09-003518
CIK 0001385830operating
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 1:58 PM ET
Size
8.3 KB
Accession
0001181431-09-003518
Insider Transaction Report
Form 4
NeurogesX IncNGSX
Bley Keith R
SVP Nonclinical R & D
Transactions
- Award
Employees Stock Option (right to buy)
2009-01-15+30,000→ 30,000 totalExercise: $1.25From: 2009-02-15Exp: 2019-01-15→ Common Stock (30,000 underlying) - Award
Employees Stock Option (right to buy)
2009-01-15+28,172→ 28,172 totalExercise: $1.25From: 2009-01-15Exp: 2019-01-15→ Common Stock (28,172 underlying)
Footnotes (2)
- [F1]One Hundred percent (100%) of the shares subject to the option vest and become exercisable on January 15, 2009.
- [F2]In connection with 50% of shares subject to option, the achievement of certain performance criteria provides for acceleration of vesting in five equal installments of 20% each. Notwithstanding the acceleration vesting provision, 50% of the option would be 100% vested on January 15, 2015. In connection with the remaining 50% of shares subject to option, the option vests in forty-eight equal monthly installments beginning on February 15, 2009.
Documents
Issuer
NeurogesX Inc
CIK 0001385830
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001385830
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 1:58 PM ET
- Size
- 8.3 KB